ELVESCA Biotherapeutics GmbH
Welcome to ELVESCA Biotherapeutics GmbH, a start-up spin-off from the Bäumer/Berdel research group at the University of Münster! We are pleased to introduce you to our innovative technology platform for precision therapy against cancer. Because:
„We deliver precision medicine
– to cancer cells.“
About us
We founded ELVESCA Biotherapeutics GmbH in 2023 with a committed team of scientists, oncologists, investors and application specialists in the beautiful city of Münster.
ELART technology
For more than 10 years, Dr. Nicole Bäumer, Dr. Sebastian Bäumer and Prof. Wolfgang Berdel discuss the use of RNA interference for cancer.
Patents
In order to provide broad legal protection for this technology, we have filed two patents. More about that here.
Contact
We look forward to you contacting us!
